Vitamin D, K2 Plus Empagliflozin Combination in Type Two Diabetes Mellitus

NCT05417880 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

340

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Oral Hypoglycemic Agents,Oral
DRUG: Voreta
DRUG: Voreta plus SunnyD PRO

Sponsor

Scotmann Pharmaceuticals

Collaborators

[object Object]